Diabetes Medical Nutrition Therapy in Southeastern African American Women

Sponsor
Meharry Medical College (Other)
Overall Status
Recruiting
CT.gov ID
NCT04971889
Collaborator
Patient-Centered Outcomes Research Institute (Other), Matthew Walker Comprehensive Health Center (Other), Vanderbilt University (Other)
291
2
2
21.9
145.5
6.6

Study Details

Study Description

Brief Summary

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Diabetes MNT
  • Behavioral: Motivational Interviewing
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
291 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Diabetes Medical Nutrition Therapy in Southeastern African American Women
Actual Study Start Date :
Aug 3, 2021
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Diabetes MNT plus MI

--Group-based dietary/dietary motivation intervention

Behavioral: Diabetes MNT
Group-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake

Behavioral: Motivational Interviewing
Group-based support for dietary self-care motivation using culturally-adapted motivational interviewing exercise

Active Comparator: Diabetes MNT

-Group-based dietary intervention

Behavioral: Diabetes MNT
Group-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake

Outcome Measures

Primary Outcome Measures

  1. HbA1c [Baseline]

    Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

  2. Change from Baseline HbA1c [3 months]

    Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

  3. Change from Baseline HbA1c [6 months]

    Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

  4. Change from Baseline HbA1c [12 months]

    Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Secondary Outcome Measures

  1. Body Mass Index [Baseline]

    Calculated measure of body max index from height/weight measures

  2. Change from Baseline Body Mass Index [3 months]

    Calculated measure of body max index from height/weight measures

  3. Change from Baseline Body Mass Index [6 months]

    Calculated measure of body max index from height/weight measures

  4. Change from Baseline Body Mass Index [12 months]

    Calculated measure of body max index from height/weight measures

  5. LDL Cholesterol [Baseline]

    Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

  6. Change from baseline LDL Cholesterol [3 months]

    Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

  7. Change from baseline LDL Cholesterol [6 months]

    Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

  8. Change from baseline LDL Cholesterol [12 months]

    Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.

  9. Systolic Blood Pressure [Baseline]

    A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

  10. Change from baseline Systolic Blood Pressure [3 months]

    A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

  11. Change from baseline Systolic Blood Pressure [6 months]

    A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

  12. Change from baseline Systolic Blood Pressure [12 months]

    A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.

Other Outcome Measures

  1. Carbohydrate Management Attitude Scale [Baseline]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.

  2. Change from baseline Carbohydrate Management Attitude Scale [3 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.

  3. Change from baseline Carbohydrate Management Attitude Scale [6 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.

  4. Change from baseline Carbohydrate Management Attitude Scale [12 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.

  5. Fat Management Attitude Scale [Baseline]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.

  6. Change from baseline Fat Management Attitude Scale [3 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.

  7. Change from baseline Fat Management Attitude Scale [6 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.

  8. Change from baseline Fat Management Attitude Scale [12 months]

    Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.

  9. Diabetes Empowerment Scale [Baseline]

    Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.

  10. Change from baseline Diabetes Empowerment Scale [3 months]

    Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.

  11. Change from baseline Diabetes Empowerment Scale [6 months]

    Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.

  12. Change from baseline Diabetes Empowerment Scale [12 months]

    Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.

  13. Problem Areas in Diabetes Scale Questionnaire [Baseline]

    Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.

  14. Change from baseline Problem Areas in Diabetes Scale Questionnaire [3 months]

    Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.

  15. Change from baseline Problem Areas in Diabetes Scale Questionnaire [6 months]

    Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.

  16. Change from baseline Problem Areas in Diabetes Scale Questionnaire [12 months]

    Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.

  17. Situational Obstacles to Dietary Adherence Questionnaire [Baseline]

    Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.

  18. Change from baseline Situational Obstacles to Dietary Adherence Questionnaire [3 months]

    Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.

  19. Change from baseline Situational Obstacles to Dietary Adherence Questionnaire [6 months]

    Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.

  20. Change from baseline Situational Obstacles to Dietary Adherence Questionnaire [12 months]

    Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • African American

  • Female

  • Clinical diagnosis of type 2 diabetes for at least 6 months

  • At risk for development and/or progression of diabetes complications (HbA1c ≥ 7.0% AND either systolic blood pressure ≥130, LDL cholesterol ≥ 100, or BMI ≥ 30).

Exclusion Criteria:

--Observed or diagnosed psychotic disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Matthew Walker Comprehensive Health Center Nashville Tennessee United States 37208
2 Meharry Medical College Nashville Tennessee United States 37208

Sponsors and Collaborators

  • Meharry Medical College
  • Patient-Centered Outcomes Research Institute
  • Matthew Walker Comprehensive Health Center
  • Vanderbilt University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephania T. Miller-Hughes, Professor, Meharry Medical College
ClinicalTrials.gov Identifier:
NCT04971889
Other Study ID Numbers:
  • 21-02-1069
First Posted:
Jul 22, 2021
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022